Multaq and liver injury Q-and-A FINAL

First Page		Document Content
Date: 2013-07-21 06:10:20 Benzofurans Dronedarone Sulfonamides Cardiac dysrhythmia Liver transplantation Atrial fibrillation Norfloxacin European Medicines Agency Hepatotoxicity Medicine Hepatology Antiarrhythmic agents		Multaq and liver injury Q-and-A FINAL Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 130,62 KB Share Document on Facebook

	The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMPFINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS DocID: 1vrLd - View Document
	7 May 2018 EMAHuman Medicines Research and Development Support Division European Medicines Agency Guidance for applicants seeking access to PRIME scheme DocID: 1vlIp - View Document
	The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 23 January 2003 CPMP/SWP DocID: 1ucvu - View Document
	2 March 2016 EMAExternal guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use DocID: 1sVev - View Document
	European Medicines Agency: Celebrating 20 years DocID: 1sUY9 - View Document